In our study, both the FKH-1 cell line and primary AML cells were characterized by nuclear bodies co-localizing with XPO1 and DN, which disappeared upon eltanexor treatment and genetic deletion of XPO1. This evidence concerns the gene XPO1 and acute myeloid leukemia.